Enlivex (ENLV) Times Interest Earned (2014 - 2025)
Enlivex (ENLV) posted quarterly Times Interest Earned of $6.04 for Q4 2025, up 5.57% year-over-year from $5.72 in Q4 2024, and up 297.55% quarter-over-quarter from -$3.06 in Q3 2025.
Enlivex (ENLV) Times Interest Earned (2014 - 2025) Analysis & Trends
Enlivex's Times Interest Earned history runs 12 years deep, the most recent figure standing at $6.04 for Q4 2025.
- In Q4 2025, Times Interest Earned rose 5.57% year-over-year to $6.04; the TTM figure through Dec 2025 stood at $19.99 (up 474.1% YoY), while the FY2025 annual figure was -$0.39, up 8.78% from the prior year.
- Times Interest Earned for Q4 2025 stood at $6.04, up from -$3.06 in the prior quarter.
- The five-year high for Times Interest Earned was $351.27 in Q3 2021, with the low at -$914.86 in Q1 2022.
- The 5-year median for Times Interest Earned is -$4.97 (2023), against an average of -$47.46.
- Peak annual rise in Times Interest Earned reached 3898.66% in 2021, while the deepest fall reached 9660.5% in 2021.
- Enlivex's Times Interest Earned stood at -$19.63 in 2021, then surged by 35.24% to -$12.71 in 2022, then surged by 64.96% to -$4.45 in 2023, then surged by 228.48% to $5.72 in 2024, then grew by 5.57% to $6.04 in 2025.
- Business Quant data shows ENLV's Times Interest Earned at $6.04 in Q4 2025, -$3.06 in Q3 2025, and -$5.49 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Enlivex | 4.51 Mn | -1.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.04 |
| Sep 30, 2025 | -3.06 |
| Jun 30, 2025 | -5.49 |
| Mar 31, 2025 | -9.65 |
| Dec 31, 2024 | 5.72 |
| Sep 30, 2024 | -2.77 |
| Jun 30, 2024 | -3.16 |
| Mar 31, 2024 | -8.08 |
| Dec 31, 2023 | -4.45 |
| Sep 30, 2023 | 5.70 |
| Jun 30, 2023 | 29.03 |
| Mar 31, 2023 | -14.68 |
| Dec 31, 2022 | -12.71 |
| Sep 30, 2022 | -26.65 |
| Jun 30, 2022 | -1.18 |
| Mar 31, 2022 | -914.86 |
| Dec 31, 2021 | -19.63 |
| Sep 30, 2021 | 351.27 |
| Jun 30, 2021 | -238.00 |
| Mar 31, 2021 | -82.65 |